Drugdiscovery >> Drug Development >> News
1467
Views
Lemtrada is going  to be resubmitted to FDA review - drugdiscovery.com
Lemtrada is going to be resubmitted to FDA review - drugdiscovery.com


Lemtrada, ths multiple sclerosis drug of Genzyme, a Sanofi company was once rejected by Food and Drug Administration. The resubmission aims to solve problems which were pointed out by FDA previously.
Read More >>


Tags: FDA, Lemtrada, multiple sclerosis, sanpfi, Genzyme, resubmission, - April 9, 2014
Related Articles
1927
Views
Lemtrada: would Sanofi invest more into the development Lemtrada: would Sanofi invest more into the development
FDA declined one of Sanofi's drug, Lemtrada. This drug is used for treating dementia and multiple sclerosis. According to the news the demnd for multiple sclerosis drugs are growing. However, it is st Read More >>

Tags: developlment, trial, clinical trial

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013